Five CBD Review 2026: The Most Honest Drug-Test Answer in Hemp, and a Catalogue That Expires

Five (enjoyfive.com, previously known as Five CBD) is an Irvine, California brand founded in 2020 by John Larsen and now operated under Medterra. It made its name on full-spectrum products built to a 5:1 ratio of CBD to minor cannabinoids, and its current catalogue has moved decisively toward intoxicating hemp-derived THC: 15mg gummies, 10mg seltzers, 10mg chocolates and high-dose gummies, sold heavily on monthly subscription. It ships to almost all 50 states, not internationally, and is age-restricted. We priced the catalogue on July 29, 2026. This review contains affiliate links; the assessment is our own. It is informational only and not medical advice.

The Answer Nobody Else Gives Straight

Ask most hemp brands whether their products will fail a drug test and you get a hedge—"broad spectrum is THC-free," "results vary," "we cannot guarantee." Five's own FAQ says this: "Yes – Long term use of Five CBD products will result in a failed THC drug test." That is the correct answer, stated plainly, on a page the company controls, about a fact that costs it sales. Full-spectrum hemp extract contains detectable THC by design; if you use it regularly, it will show up. Five says so and moves on. We are highlighting it because we reviewed a competitor in the same week that markets a vape on "cannabinoids that don't trigger drug tests"—a claim that shifts an unverifiable risk onto a buyer who may have a job, a licence or a court order riding on the answer. Five's disclosure and that claim sit at opposite ends of how a company can treat the same question, and it is a reasonable proxy for how much of the rest of the marketing you should trust.

If you are subject to workplace, athletic or court-ordered drug testing, take Five's answer as the general rule for this entire category and not just for its own products: full-spectrum hemp will fail a THC test with regular use, and even THC-free broad-spectrum products carry residual risk. The only reliable approach if you are tested is not to use these products.

What It Costs

Prices verified from Five's own product feed on July 29, 2026. The current range is dominated by intoxicating hemp-derived THC rather than the CBD-first catalogue the brand is known for:

Fast-acting 15mg THC gummies — $34.99 for a 10-count sample, up to $146.96 for larger formats, in strain-named varieties including Pineapple Express, Blue Dream, Super Lemon Haze and Sour Diesel
Fast-acting 15mg THC gummies variety pack — $89.22
High dose gummies, 10-count — $24.99 each in Hybrid Vibes, Indica Chill and Sativa Surge
Fast-acting 10mg THC seltzers, variety pack — $39.99 to $99.58
Toffee 10mg THC milk chocolates — $39.99 to $69.99
Best sellers bundle with 5mg and 10mg gummies — $103.98; high dose gummy and drink bundle — $103.37
Quick Hits tin — $14.99; monthly D9 gummy variety subscription — $49.99 to $89.99
Subscribe & Save — a stated 25% off with free shipping, cancellable at any time

The $14.99 Quick Hits tin and the $34.99 ten-count sample are the sensible ways in. Everything else in this catalogue is a multi-pack, a bundle or a subscription, and at 15mg per gummy a large format is a lot of servings to hold—particularly given the date in the next section.

The Catalogue Has Moved Into the Category That Expires

Section 781 of the Continuing Appropriations Act, 2026 redefines hemp by total THC rather than delta-9 alone and caps finished consumable products at 0.4 milligrams of total THC per container from November 12, 2026. No delay had been enacted as of the Farm Bill the House passed on April 30, 2026. Five's current range does not survive that. A 10-count pouch of 15mg gummies holds 150mg of THC; larger formats hold considerably more. A 10mg seltzer is 25 times the per-container cap in a single can. The chocolates, the high-dose gummies and the bundles are all well above it. Even the brand's older full-spectrum CBD positioning is exposed, because the 5:1 ratio and full-spectrum extract mean detectable THC by design—which is the entire point of the product and precisely what the new definition measures. There is a particular problem with the subscription. Five pushes a monthly D9 gummy variety subscription at $49.99 to $89.99, plus 25% off across Subscribe & Save. A subscription started at the end of July 2026 has roughly three delivery cycles before the federal definition changes.

Do not start a subscription here, and do not bulk-buy. If you want to try these products, buy the $14.99 tin or a single 10-count pouch and finish it before November. If you want an intoxicating product you can keep buying, a licensed dispensary in a legal state is the only route unaffected by the federal change. State law on intoxicating hemp is also shifting ahead of that date, so check your own state before ordering.

The Testing Holds Up

On quality, Five is in the upper half of this category and there is independent corroboration, which is rarer than it should be. The company states that each batch is third-party lab tested and guaranteed free of contaminants—heavy metals, bacteria, microbial life, mycotoxins and pesticides—alongside potency verification. That is a full contaminant panel rather than the potency-only reporting many competitors offer. Being run under Medterra, an established operator, is a further point in its favour on manufacturing scale. Independently, Forbes Health's CBD testing programme assayed a Five 1500mg citrus CBD oil and reported 1666.7mg of CBD—about 11% above label—with roughly 20% minor cannabinoids, which confirms the advertised ratio of at least 5:1. Two things follow. The ratio claim, which is the brand's core differentiator, checks out under independent analysis. And the potency came in over label rather than under, marginally outside the 10% tolerance the industry uses but in the direction that shortchanges nobody. The gap, as with several brands here, is that Five does not name its testing laboratory and we could not confirm that reports are traceable to the specific batch you receive. R&R CBD remains the benchmark on that point, with named laboratories and QR-linked lot-level reports.

An independent assay confirming a brand's headline claim is worth more than any amount of on-site marketing. Five's 5:1 ratio is the thing it sells on, and an outside laboratory measured it and found it true. Ask the company which laboratory does its routine testing and whether reports are batch-specific; those are the two things still missing.

Returns, Shipping and the Fine Print

The terms are clear but narrower than they first appear:

Returns — 30 days for first-time customers, on new and unopened products only, excluding shipping fees
Subscribe & Save — a stated 25% off with free shipping, cancellable at any time
Shipping — almost all 50 states; no international or Canadian shipping
Errors and damaged orders are handled through customer care rather than the standard returns route

"New and unopened" is the phrase that matters: this is not a satisfaction guarantee, it is a change-of-mind policy. You cannot try the product and send it back if it does nothing for you. That makes the $14.99 tin and the $34.99 sample pouch the right way to test the brand—buy small deliberately, because the returns policy will not do it for you.

Safety, Dosing and Who Should Not Use This

These are intoxicating products and should be treated as such. No over-the-counter CBD product is FDA-approved for any condition, and the only FDA-approved CBD medicine is prescription Epidiolex for specific seizure disorders. The hemp-derived delta-9 THC in these gummies, seltzers and chocolates is pharmacologically the same molecule as the THC in cannabis; the distinction is agricultural and legal. Fifteen milligrams is a substantial dose for someone without tolerance. Edible onset is slow—typically 45 minutes to two hours—and taking more before the first dose lands is the most common route to an unpleasant experience: acute anxiety, panic, nausea and vomiting. "Fast-acting" formulations may shorten onset somewhat, but not enough to justify redosing early. Effects on coordination, reaction time and judgement last hours. CBD also inhibits CYP450 liver enzymes that metabolise many common medicines, making blood thinners, anti-seizure drugs, immunosuppressants and some antidepressants genuine issues to raise with a prescriber.

Do not use these products if you are under 21, pregnant or trying to conceive, breastfeeding, subject to any drug testing, or if you have a psychotic disorder or a family history of one. Avoid if you have significant cardiovascular disease or liver disease. Never combine THC with alcohol or sedatives, and do not drive. Start with half a 15mg gummy, wait a full two hours, and keep everything locked away from children and pets—flavoured, chocolate and canned formats are exactly what paediatric exposure data warns about. Poison Control is available at 1-800-222-1222.

How It Compares

Ten hemp brands reviewed now. Five sits with the better-run intoxicating operators, and against the same deadline. All prices from each brand's own store, checked July 29, 2026:

Five — 15mg THC gummies from $34.99, 10mg seltzers, 10mg chocolates, 25% subscription · full contaminant panel per batch, independent Forbes Health assay confirming the 5:1 ratio · unusually candid drug-test disclosure · catalogue above the November 12 cap · 30-day returns on unopened product only
Summit THC (our review: 6.0/10) — ISO-accredited testing through a named laboratory, accurate labelling per independent reviewers · 300-750mg per container · same cliff
Tillmans Tranquils (our review: 5.2/10) — 420mg syrups and 1,200mg gummy bags in dessert flavours · no laboratory named
Joy Organics (our review: 7.7/10) — USDA organic on a defined collection, SC Labs ISO 17025, FDA-registered cGMP facility · a THC-free line unaffected by November
R&R CBD (our review: 7.6/10) — three named labs, lot-level QR-linked COAs, 60-day money-back guarantee · the verification benchmark
Licensed state dispensaries (where legal) — regulated testing, serving-size limits, age verification at point of sale · unaffected by the federal change

Among intoxicating hemp brands, Five and Summit are the two we would pick on quality, and both face the same November problem. If you want the quality without the cliff, Joy Organics' THC-free line or R&R's CBD range give you comparable or better verification in products that remain lawful.

Honest Pros and Cons

What we would tell a friend, in both directions:

Pro — tells buyers outright that long-term use will fail a THC drug test, which almost nobody in this category does
Pro — every batch third-party tested across a full contaminant panel: heavy metals, bacteria, microbial life, mycotoxins and pesticides, plus potency
Pro — independent Forbes Health assay confirmed the 5:1 ratio and found potency about 11% above label rather than below
Pro — operated under Medterra, an established manufacturer, with a trading history back to 2020
Pro — sensible low-commitment entry points at $14.99 for the Quick Hits tin and $34.99 for a 10-count sample
Pro — 25% subscription discount with free shipping, cancellable at any time
Con — the catalogue has moved into intoxicating THC edibles, all of which exceed the 0.4mg-per-container federal cap from November 12, 2026
Con — heavy promotion of monthly subscriptions into a product class with roughly three delivery cycles left
Con — returns are 30 days, first-time customers only, and unopened product only, so you cannot try and return
Con — no testing laboratory named and batch traceability unconfirmed
Con — 15mg per gummy is a substantial dose for a new user, in strain-branded formats that invite casual use
Con — chocolate, seltzer and gummy formats need locking away from children

Who Should Pick It—and Who Should Look Elsewhere

Five fits an adult over 21 in a state where hemp THC is lawful, who wants a well-tested intoxicating edible from an operator that has been straight with them about drug testing, and who buys the tin or a single sample pouch for near-term use. On testing and candour it is among the better brands in this part of the category, and the independent confirmation of its ratio claim is a genuine mark of quality. Look elsewhere if you were about to subscribe—the timeline does not support it, and 25% off is not worth committing to a category with a federal expiry date. Look elsewhere if you are subject to drug testing, and take Five's own answer as the reason. Look elsewhere if you want lot-level traceability, where R&R does more. And look elsewhere if you want something to keep buying past this autumn: a licensed dispensary is the answer for intoxicating products, and Joy Organics or R&R for CBD. Nobody under 21, pregnant, breastfeeding, drug-tested, or with a psychotic disorder or family history of one should be buying any of this.

Common Questions

Quick answers to what buyers actually search:

How much does Five cost? — 15mg THC gummies from $34.99 for a 10-count sample up to $146.96 for larger formats, high-dose 10-counts $24.99, 10mg THC seltzer variety packs $39.99-$99.58, 10mg THC chocolates $39.99-$69.99, Quick Hits tin $14.99, monthly subscription $49.99-$89.99 with 25% off. Checked July 29, 2026.
Will Five CBD fail a drug test? — Yes, and the company says so itself: its FAQ states that long-term use of Five products will result in a failed THC drug test. If you are tested, do not use them.
Is Five CBD legit? — Yes. It is a Medterra brand trading since 2020, batch-testing across a full contaminant panel, and an independent Forbes Health assay confirmed its 5:1 ratio claim with potency about 11% above label.
What is the 5:1 ratio? — Five parts CBD to one part minor cannabinoids such as CBC, CBG and CBN. It is the brand's core differentiator and independent testing has confirmed it.
Will these products still be available? — Federal law caps finished hemp products at 0.4mg total THC per container from November 12, 2026. A 10-count pouch of 15mg gummies is 150mg, so the current range is directly affected unless Congress acts.
Can I return it if it doesn't work? — Not really. Returns are 30 days, first-time customers, new and unopened product only, excluding shipping. Buy the $14.99 tin to test the brand instead.
How much should I take? — Start with half a 15mg gummy and wait a full two hours. 'Fast-acting' shortens onset but not enough to justify redosing early.
Who owns Five? — It operates under Medterra. It was founded in 2020 by John Larsen and is based in Irvine, California.

The Bottom Line

Verdict: 6.2/10—one of the more honest and better-tested operators in intoxicating hemp, selling a catalogue with a federal expiry date and pushing subscriptions into it. Five earns real credit for two things. It states on its own FAQ that long-term use of its products will fail a THC drug test, which is the correct answer to the question buyers most need answered and one almost nobody else in this category gives straight. And its quality claims survive outside scrutiny: batch testing across a full contaminant panel, plus an independent Forbes Health assay that confirmed the 5:1 ratio and found potency slightly above label rather than below. Against that, the range has moved into 15mg THC gummies, 10mg seltzers and chocolates, every one of which sits far above the 0.4mg-per-container cap arriving on November 12, 2026—and the brand is actively promoting monthly subscriptions into a product class with about three delivery cycles left. Buy the $14.99 tin or a single sample pouch, do not subscribe, and if you want this quality of operation without the cliff edge, Joy Organics and R&R sell CBD that remains lawful. This review is informational only and not medical advice; these are intoxicating products, keep them locked away from children, and consult a licensed clinician before use if you take prescription medication. Prices and terms checked July 29, 2026 and subject to change.

Sources & References

Five — Official Site
Five — product feed, FAQ and returns/subscription terms (checked July 29, 2026)
Forbes Health — independent lab analysis of Five full-spectrum products
Continuing Appropriations Act, 2026, Section 781 — federal redefinition of hemp, effective November 12, 2026
Congressional Research Service — "Change to Federal Definition of Hemp and Implications for Federal Enforcement" (IN12620)
FDA — CBD regulatory status and Epidiolex approval
Poison Control — 1-800-222-1222